Danaher’s Cepheid Ebola Tests Highlight Diagnostics Role In Global Crises

Cepheid, a Danaher (NYSE:DHR) subsidiary, is donating and deploying Xpert Hemorrhagic Fever panel tests in response to the ...

Cepheid Delivers Xpert® Hemorrhagic Fever Panel Tests to Africa to Address Diagnostic Gaps in Ebola Bundibugyo Outbreak

Cepheid, a Danaher company, today announced it has donated an initial shipment of Xpert® Hemorrhagic Fever panel tests to ...

Fleming Initiative and Cepheid begin TRACE-CPE study on rapid CPE testing

TRACE-CPE will investigate whether rapid molecular screening for CPE can enhance infection prevention, optimise NHS resources ...
Nasdaq

Cepheid: FDA 510(k), CLIA Waiver for Point-of-Care Flu Test

Cepheid 's CPHD rapid influenza and RSV assay - the Xpert Flu+RSV Xpress test - recently won the U.S. FDA 510(k) marketing approval and the Clinical Laboratory Improvement Achievements (CLIA) waiver.
Houston Chronicle

(PRN) Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis Gains Adoption at Approximately 20 Leading U.S. Medical Centers

Managing One of the Largest Enterovirus Testing Populations, Children's Medical Center Dallas Among Leading Institutions to Quickly Adopt Cepheid's SUNNYVALE, Calif ...
Morningstar

Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness

SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...
Reuters

WHO says Cepheid rapid test will transform TB care

LONDON (Reuters) - The World Health Organization (WHO) gave its backing on Wednesday to a new molecular test for tuberculosis made by Cepheid which can rapidly diagnose TB, one of the world's biggest ...
Nasdaq

Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV

SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...